Deficiency Index

F756 citations in Alaska

Drug regimen review · Pharmacy Service Deficiencies

Ensure a licensed pharmacist perform a monthly drug regimen review, including the medical chart, following irregularity reporting guidelines in developed policies and procedures.

Data as of , released by CMS on October 8, 2026. Source: CMS Provider Data Catalog.

F756 in Alaska. Pick another state for the same tag.

Against expectation — 2025

Alaska cites F756 more often than its own record predicts

Versus expected share1.34×

1.34 times the share F756 takes of citations nationally.

Share of Alaska citations1.06%

Of every deficiency written in Alaska in 2025, this is the portion that was F756.

Each state is measured against its own expected share, not against other states.

In the surveyor’s words

What Alaska surveyors wrote

F756 findings written in Alaska, one from each severity band recorded here, most serious first.

Severity is as the surveyor wrote it. Some findings had already been corrected before the survey.

D · No harm, potential for more than minimal, isolatedAugust 28, 2026

Based on record review and interview, the facility's pharmacist failed to report medication irregularities to the attending physician, the facility's medical director, and director of nursing during monthly drug regimen reviews for 1 Resident (#5), out of 1 resident reviewed for unnecessary medications.Specifically, the pharmacist failed to recommend a gradual dose reduction (GDR - a tapering of a dose to determine if symptoms or conditions could be managed by a lower dose, or if the dose or medication could be discontinued) for an antipsychotic medication (a psychotropic medication primarily used to treat psychosis, including delusions, hallucinations, disorganized thinking or speech, and inappropriate behavior) when no GDR had been attempted, and no documentation indicating a clinical… …

Heritage Place

C · No harm, potential for minimal, widespreadNovember 9, 2018

Based on interview and facility policy review the facility failed to develop and maintain policies and procedures for the monthly drug regimen review (DRR) that included: 1) steps of reporting to the Medical Director and Director of Nursing (DON) when the pharmacist identifies an irregularity; 2) times frames for the different steps in the process; and 3) steps the pharmacist must take when he/she identifies an irregularity that requires urgent action. This failed practice placed all residents (based on a census of 17) at risk for a delay in medication management. …

Yukon Kuskokwim Elder's Home

The short window

Recent years

YearShare of Alaska citationsvs expected
20241.55%1.91×
20251.06%1.34×

Shares of citations, not counts: earlier years hold fewer inspections.

What else Alaska surveyors cite →

Deficiency Index is independent and is not affiliated with, endorsed by, or approved by CMS, Medicare, or any government agency. About this data · Report a correction